Cargando…
Aptamer-Based Sandwich Assay Formats for Detection and Discrimination of Human High- and Low-Molecular-Weight uPA for Cancer Prognosis and Diagnosis
SIMPLE SUMMARY: Urokinase-type plasminogen activator (urokinase, uPA) is a widely discussed biomarker for cancer prognosis and diagnosis. The gold standard for the determination of protein biomarkers in physiological samples is the enzyme-linked immunosorbent assay (ELISA). Here, antibodies are used...
Autores principales: | Dreymann, Nico, Sabrowski, Wiebke, Danso, Jennifer, Menger, Marcus M. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9658990/ https://www.ncbi.nlm.nih.gov/pubmed/36358641 http://dx.doi.org/10.3390/cancers14215222 |
Ejemplares similares
-
Inhibition of Human Urokinase-Type Plasminogen Activator (uPA) Enzyme Activity and Receptor Binding by DNA Aptamers as Potential Therapeutics through Binding to the Different Forms of uPA
por: Dreymann, Nico, et al.
Publicado: (2022) -
The use of high-affinity polyhistidine binders as masking probes for the selection of an NDM-1 specific aptamer
por: Sabrowski, Wiebke, et al.
Publicado: (2022) -
TEM8 functions as a receptor for uPA and mediates uPA-stimulated EGFR phosphorylation
por: Zhang, Lian-Cheng, et al.
Publicado: (2018) -
Independent validation of stromal uPA in ABCSG-08: Level 1b evidence for the prognostic value of uPA immunohistochemistry
por: Singer, C.F., et al.
Publicado: (2022) -
The uPA/uPAR system in astrocytic wound healing
por: Yepes, Manuel
Publicado: (2022)